2007

 TitoloAutoriRivistaIF 2008IF 2014
46ABERRANT METHYLATION WITHIN RUNX3 CpG ISLAND ASSOCIATED WITH THE NUCLEAR AND MITOCHONDRIAL MICROSATELLITE INSTABILITY IN SPORADIC GASTRIC CANCERS. RESULTS OF A GOIM PROSPECTIVE STUDYG. Gargano, D. Calcara, S. Corsale, V. Agnese, C. Intrivici, F. Fulfaro, G. Pantuso, M. Cajozzo, V. Morello, R.M. Tomasino, L. Ottini, G. Colucci, V. Bazan, A. Russo:Ann. Oncol., 2007; 18 (suppl. 6): pagg. 103-1094.9357.04
47SECOND-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CARCINOMA: A MULTICENTER SURVEY OF THE GRUPPO ONCOLOGICO ITALIA MERIDIONALE ON THE ACTIVITY AND SAFETY OF THE FOLFOX4 REGIMEN IN CLINICAL PRACTICEV. Gebbia, E. Maiello, F. Giuliani, N. Borsellino, M. Caruso, G. Di Maggio, F. Ferra, R. Bordonaro, F. Verderame, P. Tralongo, L. Di Cristina, R. Agueli, P. Russo, G. ColucciAnn. Oncol., 2007; 18 (suppl. 6): pagg. 124-1274.9357.04
48ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN, LEUCOVORIN, 5-FLUOROURACIL AND ETOPOSIDE REGIMEN IN RESECTED GASTRIC CANCER PATIENTS: A RANDOMIZED PHASE III TRIAL BY GRUPPO ONCOLOGICO ITALIA MERIDIONALE (GOIM 9602 STUDY)F. De Vita, F. Giuliani, M. Orditura, E. Maiello, G. Galizia, N. Di Martino, F. Montemurro, G. Carten, L. Manzione, S. Romito, V. Gebbia, F. Ciardiello, G. Catalano, G. Colucci:Annals of Oncology, 2007; 18 (suppl. 8): 1354-584.9357.04
49SAFETY AND ACTIVITY OF TRASTUZUMAB-CONTAINING THERAPIES FOR THE TREATMENT OF METASTATIC BREAST CANCER: OUR LONG-TERM CLINICAL EXPERIENCE (GOIM STUDY).V. Adamo, T. Franchina, B. Adamo, G. Ferraro, R. Rossello, M. Maugeri Sacc?, C. Scibilia, M.R. Valerio, A. Russo:Ann Oncol. 2007; ; 18 (suppl. 6): pagg. 11-54.9357.04
50LIPOSOMAL-ENCAPSULATED DOXORUBICIN PLUS CYCLOPHOSPHAMIDE AS IRST LINE THERAPY IN METASTATIC BREAST CANCER: A PHASE II MULTICENTRIC STUDYF. Giotta, V. Lorusso, E. Maiello, G. Filippelli, M.R. Valerio, M. Caruso, F. Verderame, A. Latorre, G. Colucci:Ann. Oncol., 2007; 18 (suppl. 6): pagg. 66-694.9357.04